Drug Patents owned by Synthon Pharms

1. List of Amlodipine Besylate drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6828339 SYNTHON PHARMS Amlodipine salt forms and processes for preparing them
Nov, 2022

(6 months ago)

Drugs and Companies using AMLODIPINE BESYLATE ingredient

Market Authorisation Date: 27 September, 2007

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

AMLODIPINE BESYLATE family patents

3

United States

1

Australia

1

Netherlands

1

Norway

1

Argentina

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in